Stay updated on Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Sign up to get notified when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2; the page still displays a 403 error.
    Difference
    0.2%
    Check dated 2026-11-03T19:38:05.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    An NIH-wide notice about website updates and terminology appears above the 403 error page, and the site revision label changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:22:36.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The footer’s site revision changes from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-06T19:26:43.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study details, indicating access to the record is blocked. This reflects an access/permission issue rather than a content change on the study record.
    Difference
    19%
    Check dated 2026-09-22T22:37:10.000Z thumbnail image
  6. Check
    50 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.6 to v3.7.0, signaling a front-end update. This change appears to be a metadata update and does not alter the study data or how to participate.
    Difference
    0.1%
    Check dated 2026-09-15T21:55:10.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6, signaling a new page revision. This is a metadata/version update and does not modify substantive content visible to users.
    Difference
    0.1%
    Check dated 2026-09-01T19:47:20.000Z thumbnail image

Stay in the know with updates to Nivolumab with 5-azacytidine in Childhood AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab with 5-azacytidine in Childhood AML Clinical Trial page.